These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2405185)

  • 1. Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation.
    Sheinfeld J; Reuter VE; Melamed MR; Fair WR; Morse M; Sogani PC; Herr HW; Whitmore WF; Cordon-Cardo C
    J Urol; 1990 Feb; 143(2):285-8. PubMed ID: 2405185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lewis X antigen immunostaining in the diagnosis of transitional cell carcinoma.
    Loy TS; Alexander CJ; Calaluce RD
    Mod Pathol; 1995 Aug; 8(6):587-90. PubMed ID: 8532688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine.
    Golijanin D; Sherman Y; Shapiro A; Pode D
    Urology; 1995 Aug; 46(2):173-7. PubMed ID: 7624989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood group antigens in normal and neoplastic urothelium.
    Sheinfeld J; Reuter VE; Sarkis AS; Cordon-Cardo C
    J Cell Biochem Suppl; 1992; 16I():50-5. PubMed ID: 1305688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Lewis X antigen and deoxyribonucleic acid image cytometry to increase sensitivity of urinary cytology in transitional cell carcinoma of the bladder.
    Planz B; Striepecke E; Jakse G; Böcking A
    J Urol; 1998 Feb; 159(2):384-7; discussion 387-8. PubMed ID: 9649244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigens.
    Sagerman PM; Saigo PE; Sheinfeld J; Charitonowics E; Cordon-Cardo C
    Acta Cytol; 1994; 38(4):517-23. PubMed ID: 7913791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
    Juhl BR
    Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests.
    Friedrich MG; Hellstern A; Hautmann SH; Graefen M; Conrad S; Huland E; Huland H
    J Urol; 2002 Aug; 168(2):470-4. PubMed ID: 12131290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of bladder cancer with urinary cytology, immunocytology and DNA-image-cytometry.
    Planz B; Synek C; Deix T; Böcking A; Marberger M
    Anal Cell Pathol; 2001; 22(3):103-9. PubMed ID: 11455029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of blood group antigens in bladder cancer: current concepts.
    Sheinfeld J; Reuter VE; Fair WR; Cordon-Cardo C
    Semin Surg Oncol; 1992; 8(5):308-15. PubMed ID: 1462102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood group ABO and Lewis antigen expression during neoplastic progression of human urothelium. Immunohistochemical study of type 1 chain structures.
    Orntoft TF; Nielsen MJ; Wolf H; Olsen S; Clausen H; Hakomori S; Dabelsteen E
    Cancer; 1987 Dec; 60(11):2641-8. PubMed ID: 3315174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of monoclonal antibody E48 in diagnosing transitional cell carcinoma of urinary bladder.
    Torenbeek R; Blomjous CE; Quak JJ; Ybema S; Meijer CJ
    J Clin Pathol; 1992 Apr; 45(4):303-7. PubMed ID: 1374431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thomsen-Friedenreich-related antigen in non-neoplastic ureter urothelium and transitional cell tumours of the urinary bladder. An immunohistochemical study employing the monoclonal antibody 49H.8.
    Juhl BR; Hartzen SH; Hainau B
    Acta Pathol Microbiol Immunol Scand A; 1987 Mar; 95(2):83-91. PubMed ID: 3551496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells.
    Bonner RB; Hemstreet GP; Fradet Y; Rao JY; Min KW; Hurst RE
    Cancer; 1993 Oct; 72(8):2461-9. PubMed ID: 8402463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of a tumor-cell-derived collagenase-stimulatory factor in urothelial carcinoma: its usefulness as a tumor marker for bladder cancers.
    Muraoka K; Nabeshima K; Murayama T; Biswas C; Koono M
    Int J Cancer; 1993 Aug; 55(1):19-26. PubMed ID: 8344748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood group-related antigens in human urothelium: enhanced expression of precursor, LeX, and LeY determinants in urothelial carcinoma.
    Cordon-Cardo C; Reuter VE; Lloyd KO; Sheinfeld J; Fair WR; Old LJ; Melamed MR
    Cancer Res; 1988 Jul; 48(14):4113-20. PubMed ID: 2454735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of blood group surface antigens of urinary bladder tumours using monoclonal antibodies with the avidin-biotin complex technique.
    Tan LB; Chiang C; Huang CH; Lin LM
    Int Urol Nephrol; 1992; 24(3):255-64. PubMed ID: 1399382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avidin-biotin technique is more sensitive than lectin assay for detecting the Thomsen-Friedenreich antigen (T-antigen) in transitional cell carcinoma of the bladder.
    McAlpine RG; Javadpour N; Vafier JA; Worsham GF; O'Connell KJ
    J Surg Oncol; 1984 Dec; 27(4):255-9. PubMed ID: 6389987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.